ClinicalTrialsFinder

Refractory B-Cell Lymphoma Clinical Trials in Barcelona, Barcelona

1 recruitingBarcelona, Barcelona, Spain

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

B-cell Lymphoma RecurrentRefractory B-Cell Lymphoma
Instituto de Investigación Biomédica de Salamanca27 enrolled8 locationsNCT06378190